4//SEC Filing
RXi Pharmaceuticals Corp 4
Accession 0001209191-17-041790
$PHIOCIK 0001533040operating
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:23 AM ET
Size
4.5 KB
Accession
0001209191-17-041790
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Purchase
Common stock, $0.0001 par value
2017-06-23$0.62/sh+3,500$2,170→ 3,500 total
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001533040
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 8:23 AM ET
- Size
- 4.5 KB